A medical records based study for optimization and evaluation of the comprehensive diagnosis and treatment of novel coronavirus pneumonia (COVID-19) and the assessment of risk factors for severe pneumonia

Optimization and evaluation of the comprehensive diagnosis and treatment of novel coronavirus pneumonia (COVID-19) and the assessment of risk factors for severe pneumonia

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030095

Enrollment

Unknown

Registered

2020-02-23

Start date

2020-02-23

Completion date

Unknown

Last updated

2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

2019 - nCoV pneumonia

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Viral nucleic acid test positive

Exclusion criteria

Exclusion criteria: Viral nucleic acid test negative

Design outcomes

Primary

Measure	Time frame
detection of virus nucleic acid;	—

Countries

China

Contacts

Public ContactWei Zhang

The First Affiliated Hospital of Nanchang University

zhangweiliuxin@163.com+86 13707089183

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026